IYH ETF Analysis: U.S. Healthcare | NYSE
Health | NYSE, USA | Market Cap: 3.693m USD | 12M Return: 25.5% | US4642877629 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 31.1M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The iShares U.S. Healthcare ETF (IYH) is a passively managed fund that seeks to track the performance of the U.S. healthcare equity sector by investing at least 80% of its assets in the component securities of its underlying index. Because the fund is non-diversified, it may hold a more concentrated portfolio of healthcare-related issuers compared to diversified ETFs.
The healthcare sector typically encompasses companies involved in pharmaceuticals, biotechnology, medical devices, healthcare providers, insurers, and related industries, making the fund a vehicle for targeted exposure to this segment of the U.S. equity market.
- GLP-1 obesity drug sales drive pharma revenue higher
- Drug pricing reform and Medicare negotiation pressure sector margins
- Aging demographics sustain long term healthcare demand and earnings growth
As of September 22, 2026, the stock is trading at USD 71.61 with a total of 392,027 shares traded. Over the past week, the price has changed by +1.32%, over one month by -2.82%, over three months by +13.65% and over the past year by +25.47%.
Current recommended Stop Loss: 70.40 (which is 1.7% or 1.3 ATR below the current price).
U.S. Healthcare has no consensus analysts rating.